MovDisordV3, Ncbi, Merge, bibRecord, 002248

Gabapentin-Induced myoclonus: case report.

Identifieur interne : 002248 ( Ncbi/Merge ); précédent : 002247; suivant : 002249

Gabapentin-Induced myoclonus: case report.

Auteurs : Fahrettin Ege ; Yusuf Koçak ; Ayse P. Titiz ; Semra Mungan Oztürk ; Serefnur Oztürk ; Senay Ozbakir

Source :

Movement disorders : official journal of the Movement Disorder Society [ 1531-8257 ] ; 2008.

RBID : pubmed:18702113

English descriptors

KwdEn :
- Aged, 80 and over, Amines (adverse effects), Antiparkinson Agents (adverse effects), Cyclohexanecarboxylic Acids (adverse effects), Humans, Male, Myoclonus (chemically induced), Parkinson Disease (drug therapy), gamma-Aminobutyric Acid (adverse effects).
MESH :
- chemical , adverse effects : Amines, Antiparkinson Agents, Cyclohexanecarboxylic Acids, gamma-Aminobutyric Acid.
- chemically induced : Myoclonus.
- drug therapy : Parkinson Disease.
- Aged, 80 and over, Humans, Male.

DOI: 10.1002/mds.21911
PubMed: 18702113

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 002115
to stream PubMed, to step Curation: 002115
to stream PubMed, to step Checkpoint: 002278

Links to Exploration step

pubmed:18702113

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Gabapentin-Induced myoclonus: case report.</title>
<author><name sortKey="Ege, Fahrettin" sort="Ege, Fahrettin" uniqKey="Ege F" first="Fahrettin" last="Ege">Fahrettin Ege</name>
</author>
<author><name sortKey="Kocak, Yusuf" sort="Kocak, Yusuf" uniqKey="Kocak Y" first="Yusuf" last="Koçak">Yusuf Koçak</name>
</author>
<author><name sortKey="Titiz, Ayse P" sort="Titiz, Ayse P" uniqKey="Titiz A" first="Ayse P" last="Titiz">Ayse P. Titiz</name>
</author>
<author><name sortKey="Ozturk, Semra Mungan" sort="Ozturk, Semra Mungan" uniqKey="Ozturk S" first="Semra Mungan" last="Oztürk">Semra Mungan Oztürk</name>
</author>
<author><name sortKey="Ozturk, Serefnur" sort="Ozturk, Serefnur" uniqKey="Ozturk S" first="Serefnur" last="Oztürk">Serefnur Oztürk</name>
</author>
<author><name sortKey="Ozbakir, Senay" sort="Ozbakir, Senay" uniqKey="Ozbakir S" first="Senay" last="Ozbakir">Senay Ozbakir</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2008">2008</date>
<idno type="doi">10.1002/mds.21911</idno>
<idno type="RBID">pubmed:18702113</idno>
<idno type="pmid">18702113</idno>
<idno type="wicri:Area/PubMed/Corpus">002115</idno>
<idno type="wicri:Area/PubMed/Curation">002115</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002278</idno>
<idno type="wicri:Area/Ncbi/Merge">002248</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Gabapentin-Induced myoclonus: case report.</title>
<author><name sortKey="Ege, Fahrettin" sort="Ege, Fahrettin" uniqKey="Ege F" first="Fahrettin" last="Ege">Fahrettin Ege</name>
</author>
<author><name sortKey="Kocak, Yusuf" sort="Kocak, Yusuf" uniqKey="Kocak Y" first="Yusuf" last="Koçak">Yusuf Koçak</name>
</author>
<author><name sortKey="Titiz, Ayse P" sort="Titiz, Ayse P" uniqKey="Titiz A" first="Ayse P" last="Titiz">Ayse P. Titiz</name>
</author>
<author><name sortKey="Ozturk, Semra Mungan" sort="Ozturk, Semra Mungan" uniqKey="Ozturk S" first="Semra Mungan" last="Oztürk">Semra Mungan Oztürk</name>
</author>
<author><name sortKey="Ozturk, Serefnur" sort="Ozturk, Serefnur" uniqKey="Ozturk S" first="Serefnur" last="Oztürk">Serefnur Oztürk</name>
</author>
<author><name sortKey="Ozbakir, Senay" sort="Ozbakir, Senay" uniqKey="Ozbakir S" first="Senay" last="Ozbakir">Senay Ozbakir</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="eISSN">1531-8257</idno>
<imprint><date when="2008" type="published">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged, 80 and over</term>
<term>Amines (adverse effects)</term>
<term>Antiparkinson Agents (adverse effects)</term>
<term>Cyclohexanecarboxylic Acids (adverse effects)</term>
<term>Humans</term>
<term>Male</term>
<term>Myoclonus (chemically induced)</term>
<term>Parkinson Disease (drug therapy)</term>
<term>gamma-Aminobutyric Acid (adverse effects)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Amines</term>
<term>Antiparkinson Agents</term>
<term>Cyclohexanecarboxylic Acids</term>
<term>gamma-Aminobutyric Acid</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Myoclonus</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged, 80 and over</term>
<term>Humans</term>
<term>Male</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">18702113</PMID>
<DateCreated><Year>2008</Year>
<Month>11</Month>
<Day>04</Day>
</DateCreated>
<DateCompleted><Year>2009</Year>
<Month>04</Month>
<Day>08</Day>
</DateCompleted>
<DateRevised><Year>2013</Year>
<Month>06</Month>
<Day>11</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1531-8257</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>23</Volume>
<Issue>13</Issue>
<PubDate><Year>2008</Year>
<Month>Oct</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>Gabapentin-Induced myoclonus: case report.</ArticleTitle>
<Pagination><MedlinePgn>1947-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/mds.21911</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ege</LastName>
<ForeName>Fahrettin</ForeName>
<Initials>F</Initials>
</Author>
<Author ValidYN="Y"><LastName>Koçak</LastName>
<ForeName>Yusuf</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y"><LastName>Titiz</LastName>
<ForeName>Ayse P</ForeName>
<Initials>AP</Initials>
</Author>
<Author ValidYN="Y"><LastName>Oztürk</LastName>
<ForeName>Semra Mungan</ForeName>
<Initials>SM</Initials>
</Author>
<Author ValidYN="Y"><LastName>Oztürk</LastName>
<ForeName>Serefnur</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y"><LastName>Ozbakir</LastName>
<ForeName>Senay</ForeName>
<Initials>S</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000588">Amines</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000978">Antiparkinson Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D003509">Cyclohexanecarboxylic Acids</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>56-12-2</RegistryNumber>
<NameOfSubstance UI="D005680">gamma-Aminobutyric Acid</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>6CW7F3G59X</RegistryNumber>
<NameOfSubstance UI="C040029">gabapentin</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D000588">Amines</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D000978">Antiparkinson Agents</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D003509">Cyclohexanecarboxylic Acids</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D009207">Myoclonus</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000139">chemically induced</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D010300">Parkinson Disease</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005680">gamma-Aminobutyric Acid</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2008</Year>
<Month>8</Month>
<Day>15</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2009</Year>
<Month>4</Month>
<Day>9</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2008</Year>
<Month>8</Month>
<Day>15</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="doi">10.1002/mds.21911</ArticleId>
<ArticleId IdType="pubmed">18702113</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list></list>
<tree><noCountry><name sortKey="Ege, Fahrettin" sort="Ege, Fahrettin" uniqKey="Ege F" first="Fahrettin" last="Ege">Fahrettin Ege</name>
<name sortKey="Kocak, Yusuf" sort="Kocak, Yusuf" uniqKey="Kocak Y" first="Yusuf" last="Koçak">Yusuf Koçak</name>
<name sortKey="Ozbakir, Senay" sort="Ozbakir, Senay" uniqKey="Ozbakir S" first="Senay" last="Ozbakir">Senay Ozbakir</name>
<name sortKey="Ozturk, Semra Mungan" sort="Ozturk, Semra Mungan" uniqKey="Ozturk S" first="Semra Mungan" last="Oztürk">Semra Mungan Oztürk</name>
<name sortKey="Ozturk, Serefnur" sort="Ozturk, Serefnur" uniqKey="Ozturk S" first="Serefnur" last="Oztürk">Serefnur Oztürk</name>
<name sortKey="Titiz, Ayse P" sort="Titiz, Ayse P" uniqKey="Titiz A" first="Ayse P" last="Titiz">Ayse P. Titiz</name>
</noCountry>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Merge

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002248 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 002248 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Merge
   |type=    RBID
   |clé=     pubmed:18702113
   |texte=   Gabapentin-Induced myoclonus: case report.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i   -Sk "pubmed:18702113" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd   \
       | NlmPubMed2Wicri -a MovDisordV3

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Gabapentin-Induced myoclonus: case report.

Gabapentin-Induced myoclonus: case report.

Source :

English descriptors

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki